​

Alto Neuroscience (ANRO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ANRO Stock Forecast

Alto Neuroscience (ANRO) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $34.60, with a high of $50.00 and a low of $24.00. This represents a 39.63% increase from the last price of $24.78.

- $10 $20 $30 $40 $50 High: $50 Avg: $34.6 Low: $24 Last Closed Price: $24.78

ANRO Stock Rating

Alto Neuroscience stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

ANRO Price Target Upside V Benchmarks

TypeNameUpside
StockAlto Neuroscience39.63%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-36
Avg Price Target-$36.67$31.50
Last Closing Price$24.78$24.78$24.78
Upside/Downside-47.98%27.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-111--12
Jun, 26-111--12
May, 26-91--10
Apr, 26-91--10
Mar, 26-91--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 27, 2026Patrick TrucchioH.C. Wainwright$50.00$21.06137.42%101.78%
May 18, 2026Robert W. Baird$36.00$22.9856.66%45.28%
May 14, 2026Laura ChicoWedbush$24.00$22.855.03%-3.15%
Mar 16, 2026Andrew TsaiJefferies$35.00$24.7841.24%41.24%
Feb 17, 2026Thomas ShraderBTIG$28.00$16.8965.78%12.99%
Oct 20, 2025Robert W. Baird$16.00$11.0744.53%-35.43%
Oct 23, 2024Brian SkorneyRobert W. Baird$10.00$14.53-31.18%-59.64%
Jun 20, 2024Brian SkorneyRobert W. Baird$32.00$11.11188.03%29.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 17, 2026H.C. WainwrightBuyBuyhold
May 27, 2026H.C. WainwrightBuyBuyhold
May 22, 2026Wolfe ResearchOutperforminitialise
May 14, 2026WedbushNeutralNeutralhold
Mar 16, 2026JefferiesBuyBuyhold
Feb 17, 2026BTIGBuyBuyhold
Oct 23, 2024WedbushOutperformNeutraldowngrade
Oct 23, 2024Rodman & RenshawBuyNeutraldowngrade
Sep 10, 2024Cowen & Co.BuyBuyhold
Sep 03, 2024WedbushOutperforminitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.35$-2.50$-2.19---
Avg Forecast$-2.93$-2.59$-2.53$-2.73$-2.52$-2.80
High Forecast$-2.93$-2.41$-2.24$-2.22$-2.23$-2.80
Low Forecast$-2.93$-2.75$-2.95$-3.38$-2.67$-2.80
Surprise %-53.92%-3.47%-13.44%---

Revenue Forecast

$2M $4M $5M $7M $9M $11M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$10.02M$2.27M
High Forecast----$10.02M$2.27M
Low Forecast----$10.02M$2.27M
Surprise %------

Net Income Forecast

$-95M $-83M $-71M $-59M $-47M $-35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-36.30M$-61.43M$-63.24M---
Avg Forecast$-78.64M$-69.39M$-77.05M$-75.32M$-65.84M$-75.21M
High Forecast$-78.64M$-64.87M$-60.12M$-59.78M$-59.90M$-75.21M
Low Forecast$-78.64M$-73.90M$-79.21M$-90.86M$-71.77M$-75.21M
Surprise %-53.83%-11.47%-17.93%---

ANRO Forecast FAQ

Is Alto Neuroscience stock a buy?

Alto Neuroscience stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alto Neuroscience is a favorable investment for most analysts.

What is Alto Neuroscience's price target?

Alto Neuroscience's price target, set by 8 Wall Street analysts, averages $34.6 over the next 12 months. The price target range spans from $24 at the low end to $50 at the high end, suggesting a potential 39.63% change from the previous closing price of $24.78.

How does Alto Neuroscience stock forecast compare to its benchmarks?

Alto Neuroscience's stock forecast shows a 39.63% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Alto Neuroscience over the past three months?

  • July 2026: 0% Strong Buy, 91.67% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 91.67% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 90.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Alto Neuroscience’s EPS forecast?

Alto Neuroscience's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.73, marking a 24.66% increase from the reported $-2.19 in 2025. Estimates for the following years are $-2.52 in 2027, and $-2.8 in 2028.

What is Alto Neuroscience’s revenue forecast?

Alto Neuroscience's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $10.02M, and $2.27M for 2028.

What is Alto Neuroscience’s net income forecast?

Alto Neuroscience's net income forecast for the fiscal year ending in December 2026 stands at $-75.319M, representing an 19.10% increase from the reported $-63.238M in 2025. Projections indicate $-65.835M in 2027, and $-75.208M in 2028.